Does JC virus have a role in the etiology and prognosis of Egyptian colorectal carcinoma?

APMIS

Volumn 121, Issue 4, 2013, Pages 316-328

  Samaka, Rehab M ^a   Abd El Wahed, Moshira M ^a   Aiad, Hayam A ^a   Kandil, Mona A ^a   Al Sharaky, Dalia R ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Colorectal carcinoma; in situ hybridization; John Cunningham virus; Large T antigen

Indexed keywords

VIRUS T ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; EGYPT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; JC VIRUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL, TUMOR; COLORECTAL NEOPLASMS; EGYPT; FEMALE; HUMANS; IN SITU HYBRIDIZATION; JC VIRUS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84875642053     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12001     Document Type: Article

References (45)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012;62:10-29.
2. El-Bolkainy N. Gastrointestinal cancer. In: Topographic pathology of cancer. El-Bolkainy N, Nouh M, El Bolkainy T, editors. 3rd edition. Egypt: Rhone Poulenc Rorer, 2005: 5-32.
3. Mokhtar N, Gouda I, Adel I, editors. Malignant digestive system tumors. In: Cancer Pathology Registry. 2003-2004 and Time Trend Analysis. Cairo: NCI, Elsheraa Press, 2007: 55-67.
4. Madbouly KM, Senagore AJ, Mukerjee A, Hussien AM, Shehata MA, Navine P, et al. Colorectal cancer in a population with endemic schistosoma mansoni: is this an at risk population? Int J Colorectal Dis 2007;22:175-81.
5. Bahnassy A, Zekri N, El-Houssini S. El-Shehaby MR, Mahmoud R, Abdallah S, et al. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol 2004;23:4-22.
6. Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA 1999;96:7484-9.
7. Boland CR, Luciani MG, Gasche C, Goel A. Recent advances in basic science: infection, inflammation, and gastrointestinal cancer. Gut 2005;54:1321-31.
8. Darbinyan A, Siddiqui KM, Slonina D, Darbinian N, Amini S, White MK, et al. Role of JC virus agnoprotein in DNA repair. J Virol 2004;78:8593-600.
9. Burnett-Hartman AN, Newcomb PA, Potter JD. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev 2008;17:2970-9.
10. Del Valle L, White MK, Khalili K. Potential mechanisms of the human polyomavirus JC in neural oncogenesis. J Neuropathol Exp Neurol 2008;67:729-40.
11. Niv Y, Goel A, Boland CR. JC virus and colorectal cancer: a possible trigger in the chromosomal instability pathways. Curr Opin Gastroenterol 2005;21:85-9.
12. Hori R, Murai Y, Tsuneyama K, Abdel-Aziz HO, Nomoto K, Takahashi H, et al. Detection of JC virus DNA sequences in colorectal cancers in Japan. Virchows Arch 2005;447:723-30.
13. Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P, et al. Carcinoma of the colon and rectum. In: WHO Classification of Tumors. Pathology, and Genetics of Tumors of the Digestive System. Hamilton SR, Aaltonen LA, editors. Lyon, France: IARC Press, 2000: 103-34.
14. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th ed of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.
15. Marinho VF, Metze K, Sanches FS, Rocha GF, Gobbi H. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of high prognosis. BMC Cancer 2008;29:8-64.
16. Salama P, Platell C. Host response to colorectal cancer. ANZ J Surg 2008;78:745-53.
17. Acikalin MF, Oner U, Topçu I, Yaşar B, Kiper H, Colak E. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig Liver Dis 2005;37:162-9.
18. Shunyakov L, Ryan CK, Sahasrabudhe DM, Khorana AA. The influence of host response on colorectal cancer prognosis. Clin Colorectal Cancer 2004;4:38-45.
19. Casini B, Borgese L, Del Nonno F, Galati G, Izzo L, Caputo M, et al. Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues. Anticancer Res. 2005;25:1079-85.
20. Bahnassy AA, Zekri AR, El-Houssini S, El-Shehaby AM, Mahmoud MR, Abdallah S, et al. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol 2004;23:4-22.
21. Nosho K, Shima K, Kure S, Irahara N, Baba Y, Chen L, et al. JC virus T antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. Neoplasia 2009;11:87-95.
22. Theodoropoulos G, Panoussopoulos D, Papaconstantinou I, Gazouli M, Perdiki M, Bramis J, et al. Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum 2005;48:86-91.
23. Lin PY, Fung CY, Chang FP, Huang WS, Chen WC, Wang JY, et al. Prevalence and genotype identification of human JC virus in colon cancer in Taiwan. J Med Virol 2008;80:1828-34.
24. Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO. Virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol 1996;70:7004-12.
25. Newcomb PA, Bush AC, Stoner GL, Lampe JW, Potter JD, Bigler J. No evidence of an association of JC virus and colon neoplasia. Cancer Epidemiol Biomarkers Prev 2004;13:662-6.
26. Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, Ismail S, et al. Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer 1997;71:26-30.
27. Kmieciak D, Debicki S, Trzeciak WH. Occurrence rate and genotype distribution of the JC virus (JCV) in a sample from the Polish population. J Med Virol 2008;80:1079-83.
28. Giuliani L, Ronci C, Bonifacio D, Di Bonito L, Favalli C, Perno CF, et al. Detection of oncogenic DNA viruses in colorectal cancer. Anticancer Res. 2008;28:1405-10.
29. Caracciolo V, Macaluso M, D'Agostino L, Montanari M, Scheff J, Reiss K, et al. Cross-talk between T-Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma. J Cell Biochem 2010;110:182-90.
30. Gualco E, Urbanska K, Perez-Liz G, Sweet T, Peruzzi F, Reiss K, et al. IGF-IR-dependent expression of Survivin is required for T-antigen-mediated protection from apoptosis and proliferation of neural progenitors. Cell Death Differ 2010;17:439-51.
31. Piña-Oviedo S, Urbanska K, Radhakrishnan S, Sweet T, Reiss K, Khalili K, et al. Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am J Pathol 2007;170:1291-304.
32. White MK, Khalili K. Signaling pathways and polyomavirus oncoproteins: Importance in malignant transformation. Gene Ther Mol Biol 2004;8:19-30.
33. White MK, Khalili K. Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses. Oncogene 2006;25:5286-93.
34. Lassak A, Del Valle L, Peruzzi F, Wang JY, Enam S, Croul S, et al. Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem 2002;277:17231-8.
35. Khalili K, Del Valle L, Wang JY, Darbinian N, Lassak A, Safak M, et al. T-antigen of human polyomavirus JC cooperates with the IGF-IR signaling system in cerebellar tumors of the childhood-medulloblastomas. Anticancer Res 2003;23:2035-41.
36. Gan DD, Khalili K. Interaction between JCV large T-antigen and beta-catenin. Oncogene 2004;23:483-90.
37. Bhattacharyya R, Noch EK, Khalili K. A novel role of Rac1 GTPase in JCV T-antigen-mediated betacatenin stabilization. Oncogene 2007;26:7628-36.
38. Darbinyan A, Darbinian N, Safak M, Radhakrishnan S, Giordano A, Khalili K. Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 2002;21:5574-81.
39. Darbinyan A, White MK, Akan S, Radhakrishnan S, Del Valle L, Amini S, et al. Alterations of DNA damage repair pathways resulting from JCV infection. Virology 2007;364:73-86.
40. Murai Y, Zheng HC, Abdel Aziz HO, Mei H, Kutsuna T, Nakanishi Y, et al. High JC virus load in gastric cancer and adjacent non-cancerous mucosa. Cancer Sci 2007;98:25-31.
41. Enam S, Del Valle L, Lara C, Gan DD, Ortiz-Hidalgo C, Palazzo JP, et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 2002;62:7093-101.
42. Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, et al. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 2003;63:7256-62.
43. Ramael M: Causes and prevention of technical artifacts when studying simian virus 40 (SV40) in human mesotheliomas. In: Malignant Mesothelioma. Advances in Pathogenesis, Diagnosis and Translational Therapies. Pass HI, Vogelzang NJ, Carbone M, editors. New York: Springer Science and Business Media, 2005: 309-25.
44. Martins SF, Reis RM, Rodrigues AM, Baltazar F, Filho AL. Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies. World J Clin Oncol 2011;2:272-80.
45. Svagzdys S, Lesauskaite V, Pavalkis D, Nedzelskiene I, Pranys D, Tamelis A. Microvessel density as new prognostic marker after radiotherapy in rectal cancer. BMC Cancer 2009;9:95.